A Single and Multiple Dose Study of Lemborexant in Healthy Chinese Participants
Status:
Completed
Trial end date:
2021-01-13
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the pharmacokinetics (PK) of lemborexant and
metabolites (M4, M9, and M10) in plasma in healthy Chinese participants following single and
multiple oral doses of lemborexant.